News
Datavalut Gains Traction: 5 Reasons to Sell Now
Datavault (NASDAQ: DVLT) is gaining traction and is on track to begin ramping its revenue. However, a combination of factors suggests a revenue ramp won't be enough to make a difference for this
ANIP Valuation: Does 9.8x Forward P/E Offer Upside?
ANI Pharmaceuticals ANIP enters mid-2026 with momentum in its Rare Disease franchise, led by ACTH-based injection Cortrophin Gel. First-quarter 2026 results reinforced that mix shift, even as the
HSTM or SIFY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Internet - Services sector have probably already heard of HealthStream (HSTM) and Sify Technologies Limited (SIFY). But which of these two stocks is more
CHDN vs. RRR: Which Stock Is the Better Value Option?
Investors interested in stocks from the Gaming sector have probably already heard of Churchill Downs (CHDN) and Red Rock Resorts (RRR). But which of these two stocks is more attractive to value
SOLV or HQY: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck
DOCS vs. HIMS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Info Systems sector have probably already heard of Doximity (DOCS) and Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best
BGC vs. MC: Which Stock Is the Better Value Option?
Investors looking for stocks in the Financial - Investment Bank sector might want to consider either BGC Group (BGC) or Moelis (MC). But which of these two companies is the best option for those
LTH vs. MTN: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Leisure and Recreation Services sector have probably already heard of Life Time Group Holdings, Inc. (LTH) and Vail Resorts (MTN). But which of these two
ANIP Stock: What's Driving Cortrophin Gel's 2026 Surge
ANI Pharmaceuticals ANIP is leaning harder into specialty therapies, and the shift is showing up clearly in its sales mix. Rare Disease is increasingly becoming the company’s growth engine, led by
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
Doximity DOCS recently announced a partnership with Aledade, a physician-led leader in value-based care, to integrate components of its Clinical AI Suite into Aledade Assist, the company’s EHR
Progressive (PGR) Down 3.2% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Progressive (PGR). Shares have lost about 3.2% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading
The PNC Financial Services Group (PNC) Down 3% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for The PNC Financial Services Group, Inc (PNC). Shares have lost about 3% in that time frame, underperforming the S&P 500.
But investors have to
Why Is Morgan Stanley (MS) Up 3.9% Since Last Earnings Report?
A month has gone by since the last earnings report for Morgan Stanley (MS). Shares have added about 3.9% in that time frame, underperforming the S&P 500.
Will the recent positive trend continue
Why Is M&T Bank (MTB) Down 5.2% Since Last Earnings Report?
It has been about a month since the last earnings report for M&T Bank Corporation (MTB). Shares have lost about 5.2% in that time frame, underperforming the S&P 500.
But investors have to be
Why Is First Horizon (FHN) Down 1.1% Since Last Earnings Report?
A month has gone by since the last earnings report for First Horizon National (FHN). Shares have lost about 1.1% in that time frame, underperforming the S&P 500.
Will the recent negative trend
JB Hunt (JBHT) Up 6.9% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for JB Hunt (JBHT). Shares have added about 6.9% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent
Can RTX's Massive Backlog Support Long-Term Revenue Growth?
RTX Corporation RTX continues to strengthen its long-term revenue outlook through a massive backlog position that reflects sustained demand across its commercial aerospace and defense businesses. As
BIIB Advances Alzheimer's Disease Drug Despite Study Missing Main Goal
Shares of Biogen BIIB declined more than 6% yesterday after the company announced that it would move its experimental tau-targeting Alzheimer’s disease (AD) drug, diranersen, into late-stage
McDonald's Company-Run Margins Draw Focus: Can Ownership Mix Help?
McDonald’s Corporation MCD delivered solid first-quarter 2026 sales momentum, with global comparable sales increasing 3.8% and U.S. comparable sales rising 3.9% on a year-over-year basis. That
2 Stocks to Watch From a Challenging Cable Television Industry
The Zacks Cable Television industry players are focusing on bundled offerings and on-demand programming to counter challenges from cord-cutting as consumers shift away from traditional pay-TV
Ovintiv Q1 Earnings Beat Estimates on Strong Production
Ovintiv Inc. OVV reported first-quarter 2026 adjusted earnings per share of $2, which beat the Zacks Consensus Estimate of $1.85. The bottom line also increased from the year-ago level of $1.42. The
How Will High Oil Prices Aid ExxonMobil's Energy Business?
The price of West Texas Intermediate (“WTI”) crude is trading at more than the $100-per-barrel mark. The high prices are being driven by ongoing tensions in the Middle East. The U.S. Energy
How High Oil Prices are Supporting BP's Energy Operations
The price of West Texas Intermediate (“WTI”) crude is trading at more than the $100-per-barrel mark. The high price is being backed by ongoing tensions in the Middle East. The U.S. Energy
RF Industries' EBITDA Leverage Improves: Can Margins Scale Further?
RF Industries Ltd. RFIL opened fiscal 2026 with an improved profitability profile, as stronger operating leverage helped the company improve earnings metrics despite a relatively stable revenue
Strategy Faces Fair-Value Pressure: Will it Hurt Stability Ahead?
Strategy Inc.’s MSTR growing exposure to fair-value accounting pressure is raising concerns about the stability of its earnings model as Bitcoin volatility continues to dominate financial


